Review
doi: 10.1196/annals.1358.004.
Immune response to premalignancy: insights from patients with monoclonal gammopathy
Affiliations
- PMID: 16461785
- DOI: 10.1196/annals.1358.004
Item in Clipboard
Review
Immune response to premalignancy: insights from patients with monoclonal gammopathy
Ann N Y Acad Sci.
2005 Dec.
Abstract
Many patients with preneoplastic gammopathy remain clinically stable, in spite of the presence of multiple genomic abnormalities in tumor cells. Our hypothesis is that the development of clinical cancer depends not just on the genomic changes in tumor cells, but also their interactions with the host-tumor microenvironment. Recent studies have shown that the host immune system is capable of responding to preneoplastic cells. Improved understanding of this response may provide novel opportunities for early detection and immune prevention of cancer.
Similar articles
-
Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy.J Exp Med. 2003 Dec 1;198(11):1753-7. doi: 10.1084/jem.20031030. Epub 2003 Nov 24. J Exp Med. 2003. PMID: 14638846 Free PMC article.
-
Abnormalities in immunoregulatory CD5+ B cells precede the diagnosis of multiple myeloma.Ann N Y Acad Sci. 1992 May 4;651:486-7. doi: 10.1111/j.1749-6632.1992.tb24653.x. Ann N Y Acad Sci. 1992. PMID: 1376067 No abstract available.
-
Context is everything: Mining the normal and preneoplastic microenvironment for insights into the diet and cancer risk conundrum.Mol Nutr Food Res. 2007 Jan;51(1):100-6. doi: 10.1002/mnfr.200600157. Mol Nutr Food Res. 2007. PMID: 17195262 Review.
-
Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?Isr Med Assoc J. 2006 Dec;8(12):840-2. Isr Med Assoc J. 2006. PMID: 17214099
-
[Neuropathy, monoclonal gammopathy and autoantibodies: how to establish a link?].Rev Neurol (Paris). 2007 Sep;163 Spec No 1:3S45-53. Rev Neurol (Paris). 2007. PMID: 18087229 Review. French.
Cited by
-
Immune surveillance of tumors.J Clin Invest. 2007 May;117(5):1137-46. doi: 10.1172/JCI31405. J Clin Invest. 2007. PMID: 17476343 Free PMC article. Review.
-
The concept of immune surveillance against tumors. The first theories.Oncotarget. 2017 Jan 24;8(4):7175-7180. doi: 10.18632/oncotarget.12739. Oncotarget. 2017. PMID: 27764780 Free PMC article. Review.
-
The FDA guidance on therapeutic cancer vaccines: the need for revision to include preventive cancer vaccines or for a new guidance dedicated to them.Cancer Prev Res (Phila). 2015 Nov;8(11):1011-6. doi: 10.1158/1940-6207.CAPR-15-0234. Epub 2015 Sep 9. Cancer Prev Res (Phila). 2015. PMID: 26353948 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
